nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—Cerebral infarction—Carmustine—malignant glioma	0.03	0.0498	CcSEcCtD
Formoterol—Oral candidiasis—Carmustine—malignant glioma	0.0154	0.0255	CcSEcCtD
Formoterol—Oral candidiasis—Temozolomide—malignant glioma	0.0149	0.0247	CcSEcCtD
Formoterol—Hypokinesia—Carmustine—malignant glioma	0.0145	0.024	CcSEcCtD
Formoterol—Lung disorder—Temozolomide—malignant glioma	0.0133	0.0221	CcSEcCtD
Formoterol—Herpes zoster—Temozolomide—malignant glioma	0.0125	0.0208	CcSEcCtD
Formoterol—Abscess—Carmustine—malignant glioma	0.0123	0.0205	CcSEcCtD
Formoterol—Injection site pain—Carmustine—malignant glioma	0.012	0.0199	CcSEcCtD
Formoterol—Viral infection—Temozolomide—malignant glioma	0.0104	0.0174	CcSEcCtD
Formoterol—Leukocytosis—Carmustine—malignant glioma	0.0104	0.0173	CcSEcCtD
Formoterol—Herpes simplex—Temozolomide—malignant glioma	0.0102	0.017	CcSEcCtD
Formoterol—Candida infection—Carmustine—malignant glioma	0.00932	0.0155	CcSEcCtD
Formoterol—Candida infection—Temozolomide—malignant glioma	0.00901	0.015	CcSEcCtD
Formoterol—Neoplasm—Carmustine—malignant glioma	0.00883	0.0147	CcSEcCtD
Formoterol—Neoplasm—Temozolomide—malignant glioma	0.00853	0.0142	CcSEcCtD
Formoterol—Abnormal vision—Carmustine—malignant glioma	0.00851	0.0141	CcSEcCtD
Formoterol—Abnormal vision—Temozolomide—malignant glioma	0.00823	0.0137	CcSEcCtD
Formoterol—Gastroenteritis—Temozolomide—malignant glioma	0.00773	0.0128	CcSEcCtD
Formoterol—Injury—Carmustine—malignant glioma	0.00771	0.0128	CcSEcCtD
Formoterol—Nasal congestion—Temozolomide—malignant glioma	0.00752	0.0125	CcSEcCtD
Formoterol—Hypokalaemia—Carmustine—malignant glioma	0.00645	0.0107	CcSEcCtD
Formoterol—Dehydration—Temozolomide—malignant glioma	0.00637	0.0106	CcSEcCtD
Formoterol—Dry skin—Temozolomide—malignant glioma	0.00628	0.0104	CcSEcCtD
Formoterol—Hypokalaemia—Temozolomide—malignant glioma	0.00623	0.0104	CcSEcCtD
Formoterol—Bronchitis—Temozolomide—malignant glioma	0.00569	0.00946	CcSEcCtD
Formoterol—Hyperglycaemia—Carmustine—malignant glioma	0.00553	0.00918	CcSEcCtD
Formoterol—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0055	0.00914	CcSEcCtD
Formoterol—Hyperglycaemia—Temozolomide—malignant glioma	0.00534	0.00887	CcSEcCtD
Formoterol—Urinary tract infection—Carmustine—malignant glioma	0.00531	0.00882	CcSEcCtD
Formoterol—Urinary tract infection—Temozolomide—malignant glioma	0.00513	0.00852	CcSEcCtD
Formoterol—Sinusitis—Temozolomide—malignant glioma	0.00495	0.00823	CcSEcCtD
Formoterol—Oedema peripheral—Carmustine—malignant glioma	0.00483	0.00803	CcSEcCtD
Formoterol—Connective tissue disorder—Carmustine—malignant glioma	0.00482	0.00801	CcSEcCtD
Formoterol—Visual impairment—Carmustine—malignant glioma	0.00472	0.00785	CcSEcCtD
Formoterol—Pharyngitis—Temozolomide—malignant glioma	0.0047	0.00781	CcSEcCtD
Formoterol—Urinary tract disorder—Temozolomide—malignant glioma	0.00468	0.00777	CcSEcCtD
Formoterol—Oedema peripheral—Temozolomide—malignant glioma	0.00467	0.00776	CcSEcCtD
Formoterol—Connective tissue disorder—Temozolomide—malignant glioma	0.00466	0.00774	CcSEcCtD
Formoterol—Urethral disorder—Temozolomide—malignant glioma	0.00464	0.00772	CcSEcCtD
Formoterol—Visual impairment—Temozolomide—malignant glioma	0.00457	0.00759	CcSEcCtD
Formoterol—Cardiac disorder—Temozolomide—malignant glioma	0.0044	0.00731	CcSEcCtD
Formoterol—Arrhythmia—Carmustine—malignant glioma	0.00438	0.00728	CcSEcCtD
Formoterol—Mental disorder—Carmustine—malignant glioma	0.0043	0.00714	CcSEcCtD
Formoterol—Immune system disorder—Temozolomide—malignant glioma	0.00428	0.00711	CcSEcCtD
Formoterol—Mediastinal disorder—Temozolomide—malignant glioma	0.00427	0.0071	CcSEcCtD
Formoterol—Malnutrition—Carmustine—malignant glioma	0.00427	0.00709	CcSEcCtD
Formoterol—Mental disorder—Temozolomide—malignant glioma	0.00415	0.0069	CcSEcCtD
Formoterol—Back pain—Carmustine—malignant glioma	0.00413	0.00686	CcSEcCtD
Formoterol—Malnutrition—Temozolomide—malignant glioma	0.00412	0.00685	CcSEcCtD
Formoterol—Dysgeusia—Temozolomide—malignant glioma	0.00404	0.00671	CcSEcCtD
Formoterol—Tremor—Carmustine—malignant glioma	0.004	0.00664	CcSEcCtD
Formoterol—Back pain—Temozolomide—malignant glioma	0.00399	0.00663	CcSEcCtD
Formoterol—Agitation—Carmustine—malignant glioma	0.00392	0.00652	CcSEcCtD
Formoterol—Tremor—Temozolomide—malignant glioma	0.00386	0.00642	CcSEcCtD
Formoterol—Ill-defined disorder—Temozolomide—malignant glioma	0.00383	0.00636	CcSEcCtD
Formoterol—Agitation—Temozolomide—malignant glioma	0.00379	0.0063	CcSEcCtD
Formoterol—Angioedema—Temozolomide—malignant glioma	0.00377	0.00626	CcSEcCtD
Formoterol—Malaise—Temozolomide—malignant glioma	0.00372	0.00618	CcSEcCtD
Formoterol—Hypertension—Carmustine—malignant glioma	0.00368	0.00612	CcSEcCtD
Formoterol—Palpitations—Temozolomide—malignant glioma	0.00364	0.00606	CcSEcCtD
Formoterol—Chest pain—Carmustine—malignant glioma	0.00363	0.00604	CcSEcCtD
Formoterol—Myalgia—Carmustine—malignant glioma	0.00363	0.00604	CcSEcCtD
Formoterol—Anxiety—Carmustine—malignant glioma	0.00362	0.00602	CcSEcCtD
Formoterol—Cough—Temozolomide—malignant glioma	0.0036	0.00598	CcSEcCtD
Formoterol—Hypertension—Temozolomide—malignant glioma	0.00356	0.00592	CcSEcCtD
Formoterol—Myalgia—Temozolomide—malignant glioma	0.00351	0.00583	CcSEcCtD
Formoterol—Arthralgia—Temozolomide—malignant glioma	0.00351	0.00583	CcSEcCtD
Formoterol—Anxiety—Temozolomide—malignant glioma	0.0035	0.00581	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00349	0.00579	CcSEcCtD
Formoterol—Oedema—Carmustine—malignant glioma	0.00348	0.00579	CcSEcCtD
Formoterol—Discomfort—Temozolomide—malignant glioma	0.00347	0.00576	CcSEcCtD
Formoterol—Infection—Carmustine—malignant glioma	0.00346	0.00575	CcSEcCtD
Formoterol—Dry mouth—Temozolomide—malignant glioma	0.00343	0.00571	CcSEcCtD
Formoterol—Tachycardia—Carmustine—malignant glioma	0.0034	0.00565	CcSEcCtD
Formoterol—Anaphylactic shock—Temozolomide—malignant glioma	0.00337	0.00559	CcSEcCtD
Formoterol—Oedema—Temozolomide—malignant glioma	0.00337	0.00559	CcSEcCtD
Formoterol—Infection—Temozolomide—malignant glioma	0.00334	0.00556	CcSEcCtD
Formoterol—Nervous system disorder—Temozolomide—malignant glioma	0.0033	0.00549	CcSEcCtD
Formoterol—Skin disorder—Temozolomide—malignant glioma	0.00327	0.00543	CcSEcCtD
Formoterol—Hypotension—Carmustine—malignant glioma	0.00325	0.00541	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00317	0.00527	CcSEcCtD
Formoterol—Insomnia—Carmustine—malignant glioma	0.00315	0.00523	CcSEcCtD
Formoterol—Dyspnoea—Carmustine—malignant glioma	0.00311	0.00516	CcSEcCtD
Formoterol—Somnolence—Carmustine—malignant glioma	0.0031	0.00515	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00307	0.0051	CcSEcCtD
Formoterol—Insomnia—Temozolomide—malignant glioma	0.00304	0.00506	CcSEcCtD
Formoterol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00301	0.005	CcSEcCtD
Formoterol—Dyspnoea—Temozolomide—malignant glioma	0.003	0.00499	CcSEcCtD
Formoterol—Somnolence—Temozolomide—malignant glioma	0.00299	0.00497	CcSEcCtD
Formoterol—Constipation—Carmustine—malignant glioma	0.00298	0.00495	CcSEcCtD
Formoterol—Pain—Carmustine—malignant glioma	0.00298	0.00495	CcSEcCtD
Formoterol—Dyspepsia—Temozolomide—malignant glioma	0.00296	0.00492	CcSEcCtD
Formoterol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00291	0.00483	CcSEcCtD
Formoterol—Fatigue—Temozolomide—malignant glioma	0.0029	0.00482	CcSEcCtD
Formoterol—Pain—Temozolomide—malignant glioma	0.00288	0.00478	CcSEcCtD
Formoterol—Constipation—Temozolomide—malignant glioma	0.00288	0.00478	CcSEcCtD
Formoterol—Feeling abnormal—Carmustine—malignant glioma	0.00287	0.00477	CcSEcCtD
Formoterol—Gastrointestinal pain—Carmustine—malignant glioma	0.00285	0.00473	CcSEcCtD
Formoterol—Feeling abnormal—Temozolomide—malignant glioma	0.00277	0.00461	CcSEcCtD
Formoterol—Abdominal pain—Carmustine—malignant glioma	0.00275	0.00458	CcSEcCtD
Formoterol—Body temperature increased—Carmustine—malignant glioma	0.00275	0.00458	CcSEcCtD
Formoterol—Gastrointestinal pain—Temozolomide—malignant glioma	0.00275	0.00457	CcSEcCtD
Formoterol—Urticaria—Temozolomide—malignant glioma	0.00267	0.00444	CcSEcCtD
Formoterol—Abdominal pain—Temozolomide—malignant glioma	0.00266	0.00442	CcSEcCtD
Formoterol—Body temperature increased—Temozolomide—malignant glioma	0.00266	0.00442	CcSEcCtD
Formoterol—Hypersensitivity—Carmustine—malignant glioma	0.00257	0.00426	CcSEcCtD
Formoterol—Asthenia—Carmustine—malignant glioma	0.0025	0.00415	CcSEcCtD
Formoterol—Hypersensitivity—Temozolomide—malignant glioma	0.00248	0.00412	CcSEcCtD
Formoterol—Asthenia—Temozolomide—malignant glioma	0.00242	0.00401	CcSEcCtD
Formoterol—Diarrhoea—Carmustine—malignant glioma	0.00238	0.00396	CcSEcCtD
Formoterol—Pruritus—Temozolomide—malignant glioma	0.00238	0.00396	CcSEcCtD
Formoterol—Dizziness—Carmustine—malignant glioma	0.0023	0.00383	CcSEcCtD
Formoterol—Diarrhoea—Temozolomide—malignant glioma	0.0023	0.00383	CcSEcCtD
Formoterol—Dizziness—Temozolomide—malignant glioma	0.00223	0.0037	CcSEcCtD
Formoterol—Vomiting—Carmustine—malignant glioma	0.00221	0.00368	CcSEcCtD
Formoterol—Rash—Carmustine—malignant glioma	0.0022	0.00365	CcSEcCtD
Formoterol—Dermatitis—Carmustine—malignant glioma	0.00219	0.00365	CcSEcCtD
Formoterol—Headache—Carmustine—malignant glioma	0.00218	0.00363	CcSEcCtD
Formoterol—Vomiting—Temozolomide—malignant glioma	0.00214	0.00356	CcSEcCtD
Formoterol—Rash—Temozolomide—malignant glioma	0.00212	0.00353	CcSEcCtD
Formoterol—Dermatitis—Temozolomide—malignant glioma	0.00212	0.00352	CcSEcCtD
Formoterol—Headache—Temozolomide—malignant glioma	0.00211	0.0035	CcSEcCtD
Formoterol—Nausea—Carmustine—malignant glioma	0.00207	0.00344	CcSEcCtD
Formoterol—Nausea—Temozolomide—malignant glioma	0.002	0.00332	CcSEcCtD
Formoterol—ADRB1—Signaling Pathways—H3F3A—malignant glioma	0.000165	0.000414	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—F2—malignant glioma	0.000164	0.000411	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCR3—malignant glioma	0.000163	0.00041	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000162	0.000407	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—BCHE—malignant glioma	0.000162	0.000406	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.000161	0.000406	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—H3F3A—malignant glioma	0.000161	0.000405	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—F2—malignant glioma	0.00016	0.000402	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—SLC5A5—malignant glioma	0.00016	0.000401	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCR3—malignant glioma	0.00016	0.000401	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—YWHAE—malignant glioma	0.000159	0.000399	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NTRK2—malignant glioma	0.000159	0.000399	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FLT1—malignant glioma	0.000158	0.000397	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—IDH2—malignant glioma	0.000158	0.000397	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DUSP6—malignant glioma	0.000158	0.000396	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000157	0.000394	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—IDH2—malignant glioma	0.000157	0.000393	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—JAG1—malignant glioma	0.000156	0.000391	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NTRK2—malignant glioma	0.000155	0.00039	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—YWHAE—malignant glioma	0.000155	0.00039	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOTCH3—malignant glioma	0.000155	0.000389	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FLT1—malignant glioma	0.000155	0.000389	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DUSP6—malignant glioma	0.000154	0.000387	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000153	0.000385	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FBXW7—malignant glioma	0.000152	0.000383	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—JAG1—malignant glioma	0.000152	0.000382	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	0.000152	0.00038	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—BDKRB2—malignant glioma	0.000149	0.000375	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FBXW7—malignant glioma	0.000149	0.000374	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—F2—malignant glioma	0.000149	0.000374	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000149	0.000373	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—IDH1—malignant glioma	0.000148	0.000371	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000148	0.000371	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000147	0.00037	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	0.000146	0.000367	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—F2—malignant glioma	0.000145	0.000365	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AKT2—malignant glioma	0.000143	0.00036	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SPHK1—malignant glioma	0.000143	0.000359	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3CG—malignant glioma	0.000142	0.000357	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	0.00014	0.000352	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2C18—malignant glioma	0.00014	0.000352	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PTPN11—malignant glioma	0.00014	0.000351	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	0.000139	0.00035	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOTCH2—malignant glioma	0.000139	0.000349	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000138	0.000346	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	0.000137	0.000344	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—KNG1—malignant glioma	0.000136	0.000341	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	0.000136	0.000341	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—IDH1—malignant glioma	0.000136	0.000341	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000135	0.000339	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—IDH1—malignant glioma	0.000135	0.000338	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—KNG1—malignant glioma	0.000133	0.000334	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000132	0.000332	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000131	0.00033	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SPHK1—malignant glioma	0.00013	0.000327	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AKT2—malignant glioma	0.00013	0.000327	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NTRK1—malignant glioma	0.00013	0.000325	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000129	0.000323	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTP1—malignant glioma	0.000129	0.000323	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000128	0.000321	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AKT2—malignant glioma	0.000127	0.00032	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NTRK1—malignant glioma	0.000127	0.000318	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAT—malignant glioma	0.000125	0.000315	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3CD—malignant glioma	0.000125	0.000314	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	0.000122	0.000307	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP3—malignant glioma	0.00012	0.000302	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00012	0.000302	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00012	0.000302	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PIK3CB—malignant glioma	0.00012	0.000302	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	0.000119	0.0003	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NCOR1—malignant glioma	0.000118	0.000297	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP3—malignant glioma	0.000118	0.000296	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000117	0.000295	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	0.000117	0.000293	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000116	0.000292	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTK2—malignant glioma	0.000116	0.000291	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	0.000115	0.00029	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HES1—malignant glioma	0.000114	0.000286	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTK2—malignant glioma	0.000113	0.000285	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTT1—malignant glioma	0.000113	0.000284	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NCOR1—malignant glioma	0.000113	0.000284	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	0.000113	0.000284	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—RAF1—malignant glioma	0.000112	0.000281	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HES1—malignant glioma	0.000111	0.00028	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NCOR1—malignant glioma	0.000111	0.000278	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—IL2—malignant glioma	0.00011	0.000277	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00011	0.000275	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—RAF1—malignant glioma	0.000109	0.000274	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	0.000109	0.000274	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	0.000108	0.000272	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—IL2—malignant glioma	0.000108	0.000271	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	0.000107	0.000268	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS1—malignant glioma	0.000106	0.000266	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	0.000106	0.000266	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000106	0.000266	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000106	0.000266	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SPP1—malignant glioma	0.000105	0.000264	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	0.000105	0.000263	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTT1—malignant glioma	0.000104	0.000262	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTT1—malignant glioma	0.000103	0.000259	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SPP1—malignant glioma	0.000103	0.000259	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	0.000103	0.000257	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL2—malignant glioma	0.0001	0.000252	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TERT—malignant glioma	9.98e-05	0.000251	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—BCHE—malignant glioma	9.87e-05	0.000248	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL2—malignant glioma	9.8e-05	0.000246	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TERT—malignant glioma	9.76e-05	0.000245	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS1—malignant glioma	9.76e-05	0.000245	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC5A5—malignant glioma	9.74e-05	0.000245	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PDGFB—malignant glioma	9.74e-05	0.000245	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FGFR1—malignant glioma	9.69e-05	0.000243	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS1—malignant glioma	9.68e-05	0.000243	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAV1—malignant glioma	9.64e-05	0.000242	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.64e-05	0.000242	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HIF1A—malignant glioma	9.54e-05	0.00024	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDGFB—malignant glioma	9.53e-05	0.000239	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FGFR1—malignant glioma	9.48e-05	0.000238	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HIF1A—malignant glioma	9.34e-05	0.000234	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CAV1—malignant glioma	9.23e-05	0.000232	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.22e-05	0.000231	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.13e-05	0.000229	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—KDR—malignant glioma	9.13e-05	0.000229	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—BCHE—malignant glioma	9.07e-05	0.000228	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CAV1—malignant glioma	9.03e-05	0.000227	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—BCHE—malignant glioma	9e-05	0.000226	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.96e-05	0.000225	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—KDR—malignant glioma	8.93e-05	0.000224	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC5A5—malignant glioma	8.89e-05	0.000223	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FN1—malignant glioma	8.79e-05	0.000221	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—F2—malignant glioma	8.79e-05	0.000221	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CG—malignant glioma	8.78e-05	0.000221	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—BAD—malignant glioma	8.68e-05	0.000218	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	8.6e-05	0.000216	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—F2—malignant glioma	8.59e-05	0.000216	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FN1—malignant glioma	8.59e-05	0.000216	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—BAD—malignant glioma	8.49e-05	0.000213	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARG—malignant glioma	8.48e-05	0.000213	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CD80—malignant glioma	8.42e-05	0.000212	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	8.41e-05	0.000211	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	8.41e-05	0.000211	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APC—malignant glioma	8.41e-05	0.000211	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.4e-05	0.000211	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.33e-05	0.000209	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EGF—malignant glioma	8.31e-05	0.000209	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTPN11—malignant glioma	8.26e-05	0.000207	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CD80—malignant glioma	8.24e-05	0.000207	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APC—malignant glioma	8.23e-05	0.000207	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	8.23e-05	0.000207	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EGF—malignant glioma	8.13e-05	0.000204	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTPN11—malignant glioma	8.08e-05	0.000203	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.96e-05	0.0002	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—BRAF—malignant glioma	7.9e-05	0.000198	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTP1—malignant glioma	7.85e-05	0.000197	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—BRAF—malignant glioma	7.73e-05	0.000194	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CD—malignant glioma	7.72e-05	0.000194	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT2—malignant glioma	7.69e-05	0.000193	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EGFR—malignant glioma	7.66e-05	0.000192	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAT—malignant glioma	7.64e-05	0.000192	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT2—malignant glioma	7.53e-05	0.000189	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EGFR—malignant glioma	7.49e-05	0.000188	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	7.39e-05	0.000186	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	7.32e-05	0.000184	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.26e-05	0.000182	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—KRAS—malignant glioma	7.24e-05	0.000182	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	7.23e-05	0.000182	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTP1—malignant glioma	7.22e-05	0.000181	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NCOR1—malignant glioma	7.21e-05	0.000181	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	7.16e-05	0.00018	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTP1—malignant glioma	7.16e-05	0.00018	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—KRAS—malignant glioma	7.08e-05	0.000178	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FGF2—malignant glioma	7.08e-05	0.000178	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAT—malignant glioma	7.03e-05	0.000176	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAT—malignant glioma	6.96e-05	0.000175	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FGF2—malignant glioma	6.92e-05	0.000174	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CB—malignant glioma	6.73e-05	0.000169	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—malignant glioma	6.67e-05	0.000168	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	6.65e-05	0.000167	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NCOR1—malignant glioma	6.63e-05	0.000167	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MDM2—malignant glioma	6.62e-05	0.000166	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RAF1—malignant glioma	6.6e-05	0.000166	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NCOR1—malignant glioma	6.58e-05	0.000165	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ERBB2—malignant glioma	6.53e-05	0.000164	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	6.5e-05	0.000163	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MDM2—malignant glioma	6.48e-05	0.000163	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RAF1—malignant glioma	6.46e-05	0.000162	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	6.44e-05	0.000162	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ERBB2—malignant glioma	6.39e-05	0.00016	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	6.3e-05	0.000158	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCL8—malignant glioma	6.19e-05	0.000155	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCL8—malignant glioma	6.06e-05	0.000152	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	5.98e-05	0.00015	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CASP3—malignant glioma	5.93e-05	0.000149	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL2—malignant glioma	5.92e-05	0.000149	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAV1—malignant glioma	5.88e-05	0.000148	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	5.85e-05	0.000147	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTEN—malignant glioma	5.82e-05	0.000146	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CASP3—malignant glioma	5.8e-05	0.000146	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL2—malignant glioma	5.79e-05	0.000145	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.62e-05	0.000141	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP9—malignant glioma	5.6e-05	0.000141	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTEN—malignant glioma	5.57e-05	0.00014	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP9—malignant glioma	5.48e-05	0.000138	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTEN—malignant glioma	5.45e-05	0.000137	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AKT1—malignant glioma	5.43e-05	0.000136	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAV1—malignant glioma	5.41e-05	0.000136	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAV1—malignant glioma	5.36e-05	0.000135	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.36e-05	0.000135	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AKT1—malignant glioma	5.31e-05	0.000133	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARG—malignant glioma	5.17e-05	0.00013	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.12e-05	0.000129	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—malignant glioma	5.03e-05	0.000126	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—STAT3—malignant glioma	4.98e-05	0.000125	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.93e-05	0.000124	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—malignant glioma	4.92e-05	0.000124	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.88e-05	0.000123	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—STAT3—malignant glioma	4.87e-05	0.000122	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARG—malignant glioma	4.75e-05	0.000119	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARG—malignant glioma	4.71e-05	0.000118	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.71e-05	0.000118	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MYC—malignant glioma	4.63e-05	0.000116	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MYC—malignant glioma	4.53e-05	0.000114	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EGFR—malignant glioma	4.53e-05	0.000114	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EGFR—malignant glioma	4.43e-05	0.000111	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.33e-05	0.000109	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.29e-05	0.000108	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—KRAS—malignant glioma	4.28e-05	0.000107	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—KRAS—malignant glioma	4.18e-05	0.000105	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.1e-05	0.000103	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CA—malignant glioma	4.1e-05	0.000103	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—malignant glioma	4.07e-05	0.000102	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	3.93e-05	9.86e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	3.84e-05	9.65e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TP53—malignant glioma	3.8e-05	9.54e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.77e-05	9.48e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.74e-05	9.4e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—malignant glioma	3.74e-05	9.39e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TP53—malignant glioma	3.72e-05	9.33e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—malignant glioma	3.71e-05	9.31e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTEN—malignant glioma	3.55e-05	8.91e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AKT1—malignant glioma	3.35e-05	8.42e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTEN—malignant glioma	3.26e-05	8.19e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTEN—malignant glioma	3.23e-05	8.12e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT1—malignant glioma	3.21e-05	8.06e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT1—malignant glioma	3.14e-05	7.88e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.5e-05	6.28e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.3e-05	5.78e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.28e-05	5.73e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AKT1—malignant glioma	2.04e-05	5.13e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AKT1—malignant glioma	1.88e-05	4.72e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AKT1—malignant glioma	1.86e-05	4.68e-05	CbGpPWpGaD
